TickerFacts.

A business in context

EDIT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-03 · 0002063082-26-000006

  2. 4 · Ownership change

    Report date 2026-09-03 · 0001985604-26-000003

  3. 4 · Ownership change

    Report date 2026-09-03 · 0001742084-26-000003

  4. 4 · Ownership change

    Report date 2026-08-06 · 0002137699-26-000004

  5. 4 · Ownership change

    Report date 2026-08-03 · 0002063082-26-000003

  6. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001650664-26-000083

  7. 8-K · Current report

    Report date 2026-08-03 · 0001650664-26-000082 · Items 2.02,5.02,9.01

  8. 4 · Ownership change

    Report date 2026-07-28 · 0001650664-26-000076

  9. 4 · Ownership change

    Report date 2026-06-17 · 0001650664-26-000072

  10. 4 · Ownership change

    Report date 2026-06-17 · 0001650664-26-000071

  11. 8-K · Current report

    Report date 2026-06-17 · 0001650664-26-000063 · Items 5.07

  12. 8-K · Current report

    Report date 2026-05-26 · 0001104659-26-066317 · Items 1.01,8.01,9.01

  13. 8-K · Current report

    Report date 2026-05-26 · 0001104659-26-066021 · Items 8.01

  14. 8-K · Current report

    Report date 2026-05-25 · 0001104659-26-065908 · Items 7.01,8.01,9.01

  15. 8-K · Current report

    Report date 2026-05-14 · 0001650664-26-000049 · Items 7.01,8.01,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001650664-26-000045

  17. 8-K · Current report

    Report date 2026-05-05 · 0001650664-26-000043 · Items 2.02,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-04-28 · 0001650664-26-000037

  19. 8-K · Current report

    Report date 2026-04-01 · 0001650664-26-000030 · Items 4.01,9.01

  20. 8-K · Current report

    Report date 2026-03-26 · 0001650664-26-000027 · Items 7.01,8.01,9.01

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001650664-26-000017

  22. 8-K · Current report

    Report date 2026-03-09 · 0001650664-26-000013 · Items 2.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001650664-25-000156

  24. 8-K · Current report

    Report date 2025-11-10 · 0001650664-25-000153 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-10-09 · 0001650664-25-000148 · Items 7.01,8.01,9.01

  26. 8-K · Current report

    Report date 2025-09-02 · 0001650664-25-000134 · Items 7.01,8.01,9.01

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001650664-25-000125

  28. 8-K · Current report

    Report date 2025-08-12 · 0001650664-25-000123 · Items 2.02,9.01

  29. 8-K · Current report

    Report date 2025-06-12 · 0001650664-25-000106 · Items 7.01,8.01,9.01

  30. 8-K · Current report

    Report date 2025-05-29 · 0001650664-25-000086 · Items 5.02,5.03,5.07,9.01

  31. 8-K · Current report

    Report date 2025-05-14 · 0001650664-25-000081 · Items 7.01,8.01,9.01

  32. 8-K · Current report

    Report date 2025-05-13 · 0001650664-25-000077 · Items 7.01,8.01,9.01

  33. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001650664-25-000073

  34. 8-K · Current report

    Report date 2025-05-12 · 0001650664-25-000071 · Items 2.02,9.01

  35. DEF 14A · Proxy statement

    Report date 2025-04-15 · 0001650664-25-000058

  36. 8-K · Current report

    Report date 2025-03-18 · 0001650664-25-000031 · Items 5.02

  37. 10-K · Annual report

    Report date 2024-12-31 · 0001650664-25-000022

  38. 8-K · Current report

    Report date 2025-03-05 · 0001650664-25-000020 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2025-01-13 · 0001650664-25-000003 · Items 2.02,7.01,9.01

  40. 8-K · Current report

    Report date 2024-12-16 · 0001650664-24-000144 · Items 5.02

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 3 transaction rows3SGrant / award: 5 transaction rows5AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

8 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-17
2026-06-22
Connaughton BernadetteA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
51700.00.0
2026-06-17
2026-06-22
Hopfield JessicaA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
51700.00.0
2026-06-17
2026-06-22
Hirsch AndrewA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
51700.00.0
2026-06-17
2026-06-22
Scadden DavidA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
51700.00.0
2026-06-17
2026-06-22
Levy Elliott M.A · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
51700.00.0
2026-06-03
2026-06-05
Parison Amy
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock464.02.7
2026-06-03
2026-06-05
O'Neill Gilmore Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15380.02.7
2026-06-03
2026-06-05
Burkly Linda
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock731.02.7

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001650664Editas Medicine, Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
5299000AON4Q9NT2JE42
GLEIF legal name
EDITAS MEDICINE, INC.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2021-07-13T06:53:08Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Editas Medicine · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$32.31M$34.40M
2023-12-31$78.12M$85.61M
2022-12-31$19.71M$22.49M
2021-12-31$25.54M$31.47M
2020-12-31$90.73M$117.06M
2019-12-31$20.53M$26.81M
2018-12-31$31.94M$42.47M
2017-12-31$13.73M$18.70M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗